S&P assigns ‘AA-‘ rating to Piedmont Healthcare’s bonds

S&P Global Ratings assigned an “AA-” rating to Atlanta-based Piedmont Healthcare’s $404.2 million of series 2016A revenue bonds.

Advertisement

“The ‘AA-‘ rating reflects our assessment of Piedmont’s solid enterprise profile in a competitive and consolidating market and its stable and financial profile, highlighted by operating margins in excess of 5 percent for the past two fiscal years and historical pro forma maximum annual debt service greater than 5 times,” said an S&P analyst.

The outlook is stable, reflecting S&P’s view of Piedmont’s solid enterprise profile and healthy financial profile.

More articles on healthcare finance:
Fitch assigns ‘AA-‘ rating to Cedars-Sinai Medical Center’s bonds
Moody’s downgrades Sauk Prairie Memorial Hospital’s rating to ‘B1’
AHA asks judge to require HHS to resolve Medicare appeals backlog

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.